See more : PTC Therapeutics, Inc. (PTCT) Income Statement Analysis – Financial Results
Complete financial analysis of Custom Truck One Source, Inc. (CTOS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Custom Truck One Source, Inc., a leading company in the Rental & Leasing Services industry within the Industrials sector.
- Bombardier Inc. (BBD-PB.TO) Income Statement Analysis – Financial Results
- Crestchem Limited (CRSTCHM.BO) Income Statement Analysis – Financial Results
- Pasofino Gold Limited (EFRGF) Income Statement Analysis – Financial Results
- Alembic Pharmaceuticals Limited (APLLTD.NS) Income Statement Analysis – Financial Results
- Mohammed Hadi Al Rasheed and Partners Co. (9601.SR) Income Statement Analysis – Financial Results
Custom Truck One Source, Inc. (CTOS)
About Custom Truck One Source, Inc.
Custom Truck One Source, Inc. provides specialty equipment rental services to the electric utility transmission and distribution, telecommunications, rail, other infrastructure-related industries in North America. It operates through Equipment Rental Solutions, Truck and Equipment Sales, and Aftermarket Parts and Services segments. The Equipment Rental Solutions owns new and used specialty equipment, including truck-mounted aerial lifts, cranes, service trucks, dump trucks, trailers, digger derricks, and other machinery and equipment. The Truck and Equipment Sales segment offers new equipment for sale to be used for end-markets which can be modified to meet customers specific needs. The Aftermarket Parts and Services segment provides truck and equipment maintenance and repair services as well as sale of specialized aftermarket parts. The company was formerly known as Nesco Holdings, Inc. and changed its name to Custom Truck One Source, Inc. in April 2021. Custom Truck One Source, Inc. was founded in 1988 and is headquartered in Kansas City, Missouri.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.87B | 1.57B | 1.17B | 302.74M | 264.04M | 246.30M | 203.77M | 187.10M |
| Cost of Revenue | 1.41B | 1.19B | 957.14M | 226.30M | 177.49M | 1.55M | 148.27M | 157.51M |
| Gross Profit | 454.26M | 383.75M | 210.01M | 76.44M | 86.55M | 244.74M | 55.50M | 29.59M |
| Gross Profit Ratio | 24.36% | 24.39% | 17.99% | 25.25% | 32.78% | 99.37% | 27.23% | 15.81% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 228.10M | 210.87M | 155.78M | 46.41M | 37.28M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 3.30M | -210.66M | 4.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 231.40M | 210.87M | 155.78M | 46.41M | 37.28M | 32.72M | 777.47K | 25.17M |
| Other Expenses | 51.91M | 43.35M | 44.37M | 6.16M | 4.95M | 1.55M | 0.00 | 0.00 |
| Operating Expenses | 283.31M | 254.22M | 200.15M | 52.57M | 42.23M | 1.55M | 777.47K | 28.08M |
| Cost & Expenses | 1.69B | 1.44B | 1.16B | 278.86M | 219.72M | 1.55M | 777.47K | 185.59M |
| Interest Income | 18.44M | 88.91M | 72.84M | 63.20M | 63.36M | 6.68M | 0.00 | 48.20M |
| Interest Expense | 131.32M | 88.91M | 72.84M | 63.20M | 63.36M | 63.38M | 0.00 | 0.00 |
| Depreciation & Amortization | 218.99M | 223.48M | 209.07M | 82.71M | 74.56M | 67.14M | 2.86M | 2.82M |
| EBITDA | 408.38M | 359.12M | 104.84M | 94.56M | 104.88M | 110.02M | -777.47K | 4.39M |
| EBITDA Ratio | 21.90% | 24.50% | 18.71% | 33.42% | 44.38% | -0.65% | -0.38% | 2.34% |
| Operating Income | 170.95M | 161.86M | 9.29M | 17.25M | 36.02M | -1.55M | -777.47K | 1.57M |
| Operating Income Ratio | 9.17% | 10.29% | 0.80% | 5.70% | 13.64% | -0.63% | -0.38% | 0.84% |
| Total Other Income/Expenses | -112.87M | -56.58M | -135.11M | -68.60M | -69.06M | -56.99M | 0.00 | -48.01M |
| Income Before Tax | 58.08M | 46.73M | -177.08M | -51.35M | -33.04M | 5.17M | -777.47K | -46.70M |
| Income Before Tax Ratio | 3.11% | 2.97% | -15.17% | -16.96% | -12.51% | 2.10% | -0.38% | -24.96% |
| Income Tax Expense | 7.36M | 7.83M | 4.43M | -30.07M | -5.99M | -13.46M | 3.49M | 1.33M |
| Net Income | 50.71M | 38.91M | -181.50M | -21.28M | -27.05M | 5.17M | -777.47K | -48.03M |
| Net Income Ratio | 2.72% | 2.47% | -15.55% | -7.03% | -10.25% | 2.10% | -0.38% | -25.67% |
| EPS | 0.21 | 0.16 | -0.75 | -0.43 | -0.82 | 0.24 | -0.02 | -4.76 |
| EPS Diluted | 0.21 | 0.16 | -0.75 | -0.43 | -0.82 | 0.24 | -0.02 | -4.76 |
| Weighted Avg Shares Out | 245.09M | 247.15M | 241.37M | 49.06M | 33.07M | 21.66M | 50.31M | 10.10M |
| Weighted Avg Shares Out (Dil) | 245.73M | 247.71M | 241.37M | 49.06M | 33.07M | 21.66M | 50.31M | 10.10M |
Custom Truck One Source to Participate in the BofA Securities 2024 Leveraged Finance Conference
Intensity Therapeutics Presents INT230-6 Phase 1/2 Data in Sarcoma and an Overview of its Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") in a Late-Breaking Session at the 2024 Annual Connective Tissue Oncology Society Meeting (CTOS)
SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting
Custom Truck One Source, Inc. (CTOS) Q3 2024 Earnings Call Transcript
Custom Truck One Source, Inc. (CTOS) Reports Q3 Loss, Misses Revenue Estimates
Custom Truck One Source, Inc. Reports Third Quarter 2024 Results and Updates Full-Year Guidance
Custom Truck One Source to Announce Third Quarter 2024 Financial Results
Custom Truck One Source to Participate in the 23rd Annual D.A. Davidson Diversified Industrials & Services Conference
Custom Truck One Source, Inc. (CTOS) Q2 2024 Earnings Call Transcript
Custom Truck One Source, Inc. (CTOS) Reports Q2 Loss, Misses Revenue Estimates
Source: https://incomestatements.info
Category: Stock Reports